A brief survey on computational approaches to reveal drug and disease associations

Hsiang-Yuan Yeh1, Wei-Chih Lin, Yu-Fen Huang

  • 1Department of Computer Science, National Tsing Hua University, HsinChu, Taiwan.

Insights

Computational methods can reveal complex drug-disease associations, improving cancer therapies. Integrating diverse data enhances drug efficacy and safety for better disease treatment outcomes.

Area of Science:

  • Pharmacology and Pathology
  • Computational Biology
  • Genomic Medicine

Background:

  • Complex disease phenotypes, particularly cancer, arise from multifactorial alterations.
  • Current drug therapies are limited by incomplete knowledge of drug-disease associations.
  • Advancements in experimental data necessitate systematic analysis for therapeutic improvement.

Purpose of the Study:

  • To review computational methods for elucidating drug-disease associations.
  • To highlight the role of computational approaches in pharmacology and pathology.
  • To discuss the potential of advanced methods in drug discovery and development.

Main Methods:

  • Systematic integration and analysis of experimental data.
  • Application of computational methods to identify pharmacology-pathology relationships.
  • Review of existing literature on computational drug-disease association studies.

Main Results:

  • Computational methods offer insights into the complex interplay between drugs and diseases.
  • These methods facilitate the understanding of molecular targets and therapeutic effects.
  • The review demonstrates the utility of computational approaches in pharmacology.

Conclusions:

  • Computational methods are crucial for understanding drug-disease relationships.
  • Future computational techniques will leverage multi-dimensional data for enhanced drug efficacy and safety.
  • This approach promises to improve existing therapies and accelerate the development of new treatments for complex diseases.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...